Sign In
Buy LKYSF
$0.390
+0 (+0%)
At Close: Aug 17, 2022
Don't Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher
03:17pm, Wednesday, 27'th Sep 2023
Psychedelic stocks are on the rise. Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness for treating a variety of conditions.
Numinus Wellness looking to position itself at the forefront of psychedelics for healing and wellness
08:45am, Thursday, 16'th Dec 2021
Trifecta of psychedelics healing and wellness solutions Numinus Bioscience is a Health Canada-licensed lab Numinus R&D is developing psychedelic-assisted therapeutic protocols Numinus Health supports
Psychedelics Company Numinus Wellness Q4 Revenue Grows 81% YoY Thanks To Mindscape Acquisition
09:07am, Friday, 10'th Dec 2021
Psychedelics-focused mental health care company Numinus Wellness Inc. (TSXV:NUMI) (OTCQX:NUMIF) announced its fiscal fourth quarter and full-year results Thursday for the periods ended August 31,
Numinus Wellness ends fiscal 2021 with $1.5M in revenue after Mindspace Wellbeing acquisition
07:18am, Friday, 10'th Dec 2021
Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF) closed out its fiscal fourth quarter with a strong $59.2 million cash balance and improved revenue following its acquisition of Canadian healthcare start-
Numinus Wellness develops proprietary tests for screening psychedelic mushroom compounds
07:57am, Monday, 29'th Nov 2021
Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF) has announced novel, proprietary methods - developed and validated in-house - for screening psychedelic mushroom compounds. The testing will be avail
Numinus Wellness receives conditional approval for listing on the Toronto Stock Exchange
09:23am, Friday, 26'th Nov 2021
Numinus Wellness Inc said it has received conditional approval for listing on the Toronto Stock Exchange (TSX), moving up from its listing on the TSX Venture Exchange. "This is an important milesto
Numinus Wellness says it has secured two new psychedelic clinics in Canada to host key study into MDMA-assisted psychotherapy for PTSD
07:55am, Wednesday, 10'th Nov 2021
Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF) said it has secured two new psychedelic clinics in Canada to host a key study into MDMA-assisted psychotherapy for PTSD (Post-Traumatic Stress Disorder)
Numinus Wellness says it has secured two new psychedelic clinics in Canada to host key study into MDMA-assisted psychotherapy for PTSD
07:33am, Wednesday, 10'th Nov 2021
Numinus Wellness Inc said it has secured two new psychedelic clinics to host the Canadian sites of a key study into MDMA-assisted psychotherapy for PTSD. The MAPS Public Benefit Corporation (MAPS PBC)
Numinus Wellness advances Phase 1 trial on its proprietary psilocybin product PSYBINA
10:10am, Wednesday, 20'th Oct 2021
Numinus Wellness Inc. revealed that it has finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived psilocybin extract.
Numinus Wellness closes fiscal 3Q with $63.2M cash pile as its trial advances and strategic push into psychedelic neurology
08:29am, Friday, 30'th Jul 2021
Numinus Wellness Inc closed out its fiscal third quarter with a strong $63.2 million cash position, surging revenue from its clinic operation, trial advances and by making a strategic push into psyche
Numinus Wellness closes fiscal 3Q with $63.2M cash pile as its trial advances and with strategic push into psychedelic neurology
08:17am, Friday, 30'th Jul 2021
Numinus Wellness Inc closed out its fiscal third quarter with a strong $63.2 million cash position, surging revenue from its clinic operation, trial advances and by making a strategic push into psyche
Numinus Wellness gets Health Canada approval for study on MDMA-assisted therapy for PTSD
09:59am, Monday, 12'th Jul 2021
Numinus Wellness Inc (CVE:NUMI) (OTCMKTS:LKYSF) (FRA:LR23) announced it had received Health Canada approval for the MAPS-sponsored open label study of MDMA-assisted therapy for post-traumatic stress d
Numinus Wellness strikes deal to acquire Neurology Centre of Toronto, establishing psychedelic centre of excellence
11:18am, Tuesday, 06'th Jul 2021
Numinus Wellness Inc (CVE:NUMI) announced it had struck an agreement to acquire the Neurology Centre of Toronto (NCT) in a deal worth up to $1 million. The Neurology Centre is a fully operational clin
Numinus Wellness files US patent application for its proprietary rapid psilocybin production process
10:39am, Thursday, 24'th Jun 2021
Numinus Wellness Inc (CVE:NUMI) has announced that its subsidiary Numinus Bioscience Inc has filed a provisional patent application in the US for the rapid production process that generates therapeut
3 Psychedelics Stocks Getting High Thanks to the Newly Launched PSY ETF
05:22pm, Tuesday, 15'th Jun 2021
These psychedelic stocks have compelling product pipelines and have built up a great head of steam in the past month thanks to the PSY ETF. The post 3 Psychedelics Stocks Getting High Thanks to the Ne
